IGF::OT::IGF A Phase I Open Label, Dose Escalation Clinical Trial assessing the Safety, Tolerability, and Feasibility of pNGLV4aCRTE6E7L2 HPV DNA vaccine administration via Intramuscular TriGridTM Ele

University Of Wisconsin-Madison, Madison WI

Investigators

Abstract

Develop and conduct a Phase I Open Label, Dose Escalation Clinical Trial assessing the Safety, Tolerability, and Feasibility of pNGLV4aCRTE6E7L2 HPV DNA vaccine administration via Intramuscular TriGridTM Electroporation Delivery System among patients with HPV16-positive high-grade cervical intraepithelial neoplasia.